As Cell and Gene therapies  enter a new era of clinical progress, in vivo collaborations are booming. Now is the perfect time to spotlight your solutions and there is no better place than at the 4th In Vivo Cell Engineering & Gene Editing Summit. This event will provide you with exclusive access to C-Suite Executives, VPs and Directors from leading companies such as Editas Medicine, Myeloid Therapeutics, Ensoma and many more who are actively seeking solution providers. Don't miss the chance to build exclusive partnerships, strengthen your brand presence, and gain valuable exposure in a market set for exponential growth.